<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bhagyashri, S.</style></author><author><style face="normal" font="default" size="100%">Gadgil, Thorat</style></author><author><style face="normal" font="default" size="100%">Killi, Naresh</style></author><author><style face="normal" font="default" size="100%">Rathna, Gundloori V. N.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Polyhydroxyalkanoates as biomaterials</style></title><secondary-title><style face="normal" font="default" size="100%">MedChemComm</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Biomedical Applications</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer-therapy</style></keyword><keyword><style  face="normal" font="default" size="100%">Drug-delivery Systems</style></keyword><keyword><style  face="normal" font="default" size="100%">In-vitro</style></keyword><keyword><style  face="normal" font="default" size="100%">Molecular-weight</style></keyword><keyword><style  face="normal" font="default" size="100%">Poly(Ester Urethane)S</style></keyword><keyword><style  face="normal" font="default" size="100%">poly(ethylene glycol)</style></keyword><keyword><style  face="normal" font="default" size="100%">Regenerative Medicine</style></keyword><keyword><style  face="normal" font="default" size="100%">Tissue Engineering Applications</style></keyword><keyword><style  face="normal" font="default" size="100%">Vitro Antibiotic Release</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style  face="normal" font="default" size="100%">SEP</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">8</style></volume><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;span style=&quot;color: rgb(51, 51, 51); font-family: arial, helvetica, sans-serif; font-size: 13px; background-color: rgb(248, 248, 248);&quot;&gt;Polyhydroxyalkanoates (PHAs) are biopolymers synthesized by bacteria under unbalanced growth conditions. These biopolymers are considered as potential biomaterials for future applications because they are biocompatible, biodegradable, and easy to produce and functionalize with strong mechanical strength. Currently, PHAs are being extensively innovated for biomedical applications due to their prerequisite properties. The wide range of biomedical applications includes drug delivery systems, implants, tissue engineering, scaffolds, artificial organ constructs, etc. In this article we review the utility of PHAs in various forms (bulk/nano) for biomedical applications so as to bring about the future vision for PHAs as biomaterials for the advancement of research and technology.&lt;/span&gt;&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">9</style></issue><custom3><style face="normal" font="default" size="100%">Foreign</style></custom3><custom4><style face="normal" font="default" size="100%">&lt;p&gt;2.319&lt;/p&gt;</style></custom4><section><style face="normal" font="default" size="100%">1774-1787</style></section></record></records></xml>